Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity
Johan Courjon, Océane Dufies, Alexandre Robert, et al.
Blood Advances (2021) Vol. 5, Iss. 5, pp. 1523-1534
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo, Eleonora Mezzaroma, Leo F. Buckley, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108053-108053
Open Access | Times Cited: 179
Neutrophils in COVID-19: Not Innocent Bystanders
Ellen McKenna, Richard Wubben, Johana M. Isaza-Correa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 81
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases
Matae Ahn, Vivian Chih-Wei Chen, Pritisha Rozario, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2144-2159.e22
Open Access | Times Cited: 38
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Shima Makaremi, Ali Asgarzadeh, Hamed Kianfar, et al.
Inflammation Research (2022) Vol. 71, Iss. 7-8, pp. 923-947
Open Access | Times Cited: 51
Programmed cell death: the pathways to severe COVID-19?
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 49
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases
Christophe Paget, Emilie Doz, Nathalie Winter, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1188-1188
Open Access | Times Cited: 34
NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
Debashis Dutta, Jianuo Liu, Huangui Xiong
PubMed (2022) Vol. 14, Iss. 3, pp. 138-160
Closed Access | Times Cited: 32
The double sides of NLRP3 inflammasome activation in sepsis
C. Vigneron, Bénédicte F. Py, Guillaume Monneret, et al.
Clinical Science (2023) Vol. 137, Iss. 5, pp. 333-351
Closed Access | Times Cited: 18
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells
Magdalena Ambrożek-Latecka, Piotr Kozłowski, Grażyna Hoser, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients
Audrey Cambon, Christophe Guervilly, Clémence Delteil, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling
Stefanie M. Bader, L.R. Scherer, Jan Schaefer, et al.
Cell Death and Differentiation (2025)
Open Access
Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity
Julio García-Villalba, Laura Hurtado‐Navarro, Alejandro Peñín‐Franch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib
Vanio Mitev
Pharmacia (2023) Vol. 70, Iss. 4, pp. 1177-1193
Open Access | Times Cited: 13
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
Annalisa Marcuzzi, E. Melloni, Giorgio Zauli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11241-11241
Open Access | Times Cited: 29
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
Daniella M. Mizurini, Eugênio D. Hottz, Patrı́cia T. Bozza, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 29
Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2
So Yeong Cheon, Bon‐Nyeo Koo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7914-7914
Open Access | Times Cited: 25
Palmitic acid activates NLRP3 inflammasome through NF-κB and AMPK-mitophagy-ROS pathways to induce IL-1β production in large yellow croaker (Larimichthys crocea)
Xueshan Li, Kangsen Mai, Qinghui Ai
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1869, Iss. 2, pp. 159428-159428
Closed Access | Times Cited: 8
Severe COVID‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils
Vinícius Nunes Cordeiro Leal, Milena M. S. Andrade, Franciane Mouradian Emidio Teixeira, et al.
Scandinavian Journal of Immunology (2022) Vol. 97, Iss. 3
Open Access | Times Cited: 13
Breaking Bad: Inflammasome Activation by Respiratory Viruses
Julia A. Cerato, Emanuelle F. da Silva, Bárbara N. Porto
Biology (2023) Vol. 12, Iss. 7, pp. 943-943
Open Access | Times Cited: 6
Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold
Yiming Xu, Yulong Xu, Savannah Biby, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 555-571
Open Access | Times Cited: 6
Deciphering the Neurosensory Olfactory Pathway and Associated Neo-Immunometabolic Vulnerabilities Implicated in COVID-Associated Mucormycosis (CAM) and COVID-19 in a Diabetes Backdrop—A Novel Perspective
Maryada Sharma, Hari Pankaj Vanam, Naresh K. Panda, et al.
Diabetology (2022) Vol. 3, Iss. 1, pp. 193-235
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top